Benitec Biopharma: BB-301's Early OPMD Data And Cash Infusion Justify A Bullish Upgrade

Benitec Biopharma Inc. reports 100% responder rates for BB-301 with a mid-2026 FDA meeting ahead. See why BNTC stock is upgraded to buy.
JD Supra

JPM 2026: Panelists advise on early-stage financing, IP strategy, and VC expectations for leadership - Pharmaceutical & biotechnology valuations predicted to ‘raise the b…

Speaking at the 2026 J.P. Morgan Healthcare Conference, John Osborn, senior advisor in the Hogan Lovells life sciences and ...

UPS (UPS) Q4 2024 Earnings Call Transcript

Joining me today are Carol Tomé, our CEO; Brian Dykes, our CFO and a few additional members of our executive leadership team. Effective with the fourth quarter of 2024 USPS Air Cargo results have been ...
Investopedia

What Is Net Profit Margin? Formula and Examples

Adam Palasciano is a writer over three years of experience writing about personal finance, investing, student loans, and more, for outlets like GOBankingRates, FinanceBuzz, The Penny Hoarder, and Wall ...